Endometrial cancer
Conditions
Interventions
None listed
Sponsors
JGOG
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Advanced or recurrent endometrial cancer (including carcinosarcoma) registered in JGOG2055s/PEACH study 2. Patients who have not withdrawn their consent during their participation in the PEACH study and who have provided written consent to participate in this study. 3. Patients who can provide sufficient amount of tumor tissue 4. Patients who can consider donating blood or normal tissue specimens within the research subject registration period (one year from the date of permission from the head of the research institution) 5. When the principal investigator or research office determines that it is appropriate for the case to be registered in the study.
Exclusion criteria
Exclusion criteria: 1. If the period from the acquisition of tumor tissue and blood samples to the date of registration for this study (date of consent obtained) exceeds 5 years, or if it is difficult to provide a sufficient amount of tissue.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of four classifications using molecular genetic classification | — |
Secondary
| Measure | Time frame |
|---|---|
| Progression-free survival (PFS), overall survival (OS), and objective response rate (ORR) of each treatment by molecular genetic classification | — |
Countries
Japan
Contacts
Public ContactSeiichiro Takahashi
JGOG JGOG office
Outcome results
None listed